KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Charles River Laboratories International (CRL) Treasury Shares (2016 - 2025)

Charles River Laboratories International (CRL) has 17 years of Treasury Shares data on record, last reported at $363.4 million in Q3 2025.

  • For Q3 2025, Treasury Shares rose 203.82% year-over-year to $363.4 million; the TTM value through Sep 2025 reached $363.4 million, up 203.82%, while the annual FY2018 figure was $55000.0, 100.0% down from the prior year.
  • Treasury Shares reached $2.1 million in Q3 2025 per CRL's latest filing, up from $50000.0 in the prior quarter.
  • Across five years, Treasury Shares topped out at $2.1 million in Q3 2025 and bottomed at $41000.0 in Q2 2024.
  • Average Treasury Shares over 5 years is $416642.9, with a median of $108000.0 recorded in 2022.
  • Peak YoY movement for Treasury Shares: plummeted 50.82% in 2024, then surged 3712.97% in 2025.
  • A 5-year view of Treasury Shares shows it stood at $40.4 million in 2021, then fell by 4.82% to $38.5 million in 2022, then tumbled by 37.61% to $24.0 million in 2023, then soared by 398.09% to $119.6 million in 2024, then soared by 203.82% to $363.4 million in 2025.
  • Per Business Quant database, its latest 3 readings for Treasury Shares were $363.4 million in Q3 2025, $363.3 million in Q2 2025, and $356.6 million in Q1 2025.